Tag: pharmaceutical industry

Following Boehringer Ingelheim's lead, AstraZeneca pledges affordable respiratory care in the U.S., sparking calls for industry-wide reform.

This procedural dismissal effectively sidelines the pharmaceutical industry's concerted efforts to maintain control over drug pricing, marking a significant victory for proponents of healthcare reform.

Florida's groundbreaking move: importing affordable medication from Canada. Big Pharma's pushback and the FDA's historic approval — a turning point in U.S. healthcare?

A DeSmog review of hundreds of documents identifies eight arguments fielded by the industrial farming lobby to allay concerns over livestock drugs.

An analysis of the $6 billion in grants distributed by PhRMA and its member companies.

Awaiting a decision expected by June 2024, the case stands as a pivotal moment in America's ongoing struggle against opioid crisis.

Economic parity in health emergence: Sanders' rallying cry for global equity in WHO pandemic accord.

A vaccine against tuberculosis, the world’s deadliest infectious disease, slowed after its corporate owner focused on more profitable vaccines.

"Any effort by far-right Republicans to paint lowering the costs of prescription drug prices for Americans as a bad thing is laughable."

"This is the biggest defeat Big Pharma has ever suffered—and it won't be the last. We are going to keep fighting until every single person in America can get the medications they need."